Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:ARA

American Renal Associates (ARA) Stock Price, News & Analysis

American Renal Associates logo

About American Renal Associates Stock (NYSE:ARA)

Advanced Chart

Key Stats

Today's Range
$11.33
$11.52
50-Day Range
$11.46
$11.52
52-Week Range
$5.57
$11.98
Volume
9,831 shs
Average Volume
106,940 shs
Market Capitalization
$397.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ARA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for American Renal Associates and its competitors with MarketBeat's FREE daily newsletter.

ARA Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
American Renal Associates Holdings, Inc. News
See More Headlines

ARA Stock Analysis - Frequently Asked Questions

American Renal Associates Holdings, Inc. (NYSE:ARA) released its quarterly earnings results on Wednesday, November, 11th. The company reported $0.15 earnings per share for the quarter, beating analysts' consensus estimates of $0.06 by $0.09. The company had revenue of $209.69 million for the quarter, compared to analyst estimates of $211.50 million. American Renal Associates had a negative net margin of 2.04% and a negative trailing twelve-month return on equity of 3.56%.

American Renal Associates (ARA) raised $161 million in an IPO on Thursday, April 21st 2016. The company issued 7,500,000 shares at $20.00-$23.00 per share. BofA Merrill Lynch, Barclays and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that American Renal Associates investors own include Zevra Therapeutics (KMPH), Madrigal Pharmaceuticals (MDGL), Exelixis (EXEL), Gilead Sciences (GILD), Spectrum Pharmaceuticals (SPPI), AbbVie (ABBV) and Bristol Myers Squibb (BMY).

Company Calendar

Last Earnings
11/11/2020
Today
7/15/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Miscellaneous Health & Allied Services
Sub-Industry
N/A
Current Symbol
NYSE:ARA
CIK
1498068
Fax
N/A
Employees
4,977
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.26
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$13.79 million
Net Margins
-2.04%
Pretax Margin
N/A
Return on Equity
-3.56%
Return on Assets
-0.24%

Debt

Debt-to-Equity Ratio
7.54
Current Ratio
1.05
Quick Ratio
1.02

Sales & Book Value

Annual Sales
$822.52 million
Price / Sales
0.48
Cash Flow
$1.69 per share
Price / Cash Flow
6.80
Book Value
$2.59 per share
Price / Book
4.45

Miscellaneous

Outstanding Shares
34,543,000
Free Float
N/A
Market Cap
$397.94 million
Optionable
Optionable
Beta
1.11
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NYSE:ARA) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners